Nonpartisan civic infrastructure

S. 4535

BillFederalSenateIntroduced

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

About This Bill

Introduced

Congress

117th (2021–2023)

Introduced

July 14, 2022

Sponsor

Sen. Richard BurrR

Cosponsors (0)

None

View PDF ↗

Summary Full Text Comments Annotations

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position

Add a comment

to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.